Ascentage Pharma Group Internat AAPG
15.53 USD +0.17 (+1.11%)
Nov 10, 2026, 1:51 PM EST
15.50 Day range 15.50
13.46 52-week range 34.50
- YTD
- -40.82%
- 1 year
- -52.07%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 574.12M | 980.65M | 221.98M | 209.71M | |
| 525.18M | 951.57M | 191.44M | 187.71M | |
| -1.29B | -387.88M | -897.20M | -901.08M | |
| -1.24B | -405.43M | -925.64M | -882.92M | |
| -13.96 | -5.36 | -13.12 | -13.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 2.47B | 1.26B | 1.09B | 1.49B | |
| 3.95B | 2.61B | 2.49B | 2.83B | |
| 2.63B | 2.34B | 2.43B | 2.42B | |
| 1.98B | 1.67B | 1.80B | 1.79B | |
| 1.32B | 264.19M | 60.42M | 408.66M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -1.17B | -111.36M | -726.08M | -653.91M | |
| -1.00B | -362.04M | 21.92M | -384.61M | |
| 2.54B | 314.77M | 368.75M | 619.27M | |
| -27.57M | -24.29M | -46.09M | -200.94M | |
| 365.92M | -158.63M | -335.40M | -419.26M |